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1. Introduction  
An endocrine disruptor (ED) is defined by the US- Environmental Protection Agency as “an 
exogenous agent that interferes with the production, release, transport, metabolism, 
binding, action, or elimination of natural hormones in the body responsible for the 
maintenance of homeostasis, reproduction, development, and/or behavior” (U.S. EPA., 
1997). This definition encompasses a rather heterogeneous group of molecules from 
naturally occurring substances (e.g., phytoestrogens) to biochemically manufactured 
compounds such as plasticizers, pesticides, industrial solvents, pharmaceutical agents 
(diethylstilbestrol) and heavy metals. 
Endocrine disruptors were originally considered to exert their biological action through 
nuclear steroid receptors by mimicking or antagonizing natural hormone’s action (Waring & 
Harris, 2005) with the majority of them acting as pseudoestrogens and less possessing anti-
androgenic or anti-estrogenic properties ( McLachlan et al., 2006 ). Today, basic scientific 
research shows that the mechanisms are much broader than originally recognized and 
include interaction with transcriptional factors, non-nuclear steroid hormone receptors, gene 
regulation or even transgenerational effects by targeting germ cell lines (Anway & Skinner, 
2006, 2008; Tabb & Blumberg, 2006).  
In addition, targets for endocrine disruption extend beyond the traditional 
estrogen/androgen -mediated reproductive system. Within the last few years, scientists also 
have expressed concern about the potential role of EDs in increasing trends in obesity and 
diabetes, the major life-threatening diseases of modern word. At present, all hormone-
sensitive physiological systems seem to be vulnerable to EDs, including brain and 
hypothalamic neuroendocrine systems; pituitary; thyroid; cardiovascular system; mammary 
gland; adipose tissue; pancreas; ovary and uterus in females; and testes and prostate in 
males (Diamanti-Kandarakis et al., 2009). 
Undoubtedly, the issue of endocrine disruption has attracted considerable scientific 
attention with the weight of data obtained from wildlife populations, animal models and 
epidemiological studies growing extensively during the last years. After all, the 
unprecedented increase in the production and use of industrial and agricultural chemicals 
during last decades makes human exposure inevitable through multiple sources. Adults are 
exposed mainly through the ingestion of contaminated drinking water, food and breathing 
polluted air. Infants are exposed to EDs through breast milk, baby products, and polluted 
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air while fetuses are exposed through the placenta and are more vulnerable to harmful, 
irreversible, pathological changes in adult life. People occupationally exposed to pesticides, 
fungicides and industrial chemicals are considered to be at highest risk for developing an 
endocrine abnormality as well as humans acutely exposed to an accidental release of an 
endocrine disrupting chemical. 
This chapter reviews the evidence linking endocrine disrupting chemicals to a broad 
spectrum of clinical perturbations from reproduction and thyroid to metabolic regulation.A 
summarized review of literature focused on the strongest experimental data and human 
epidemiological studies targets to elucidate the underlying interactions between endocrine 
disruptors and endocrine abnormalities. 
2. Reproductive function and endocrine disruptors  
Reproductive health is traditionally considered as one of the well-studied fields in endocrine 
disruption. The effects of EDs on reproduction are amply documented in both wildlife and 
laboratory populations while interfering with human reproductive function is highly 
plausible. Establishing causality between human reproductive health and exposure to a 
certain environmental contaminant is challenging as several confounders need to be taken 
into account. 
A critical concern is the potential lag between exposure to EDs and the manifestation of a 
reproductive disorder as in humans this period may be years or decades after initial 
exposure. The timing of exposure is key to human disease as the developmental periods 
from periconception and during pregnancy, infancy, childhood, and puberty are considered 
as critical and sensitive windows of susceptibility to environmental insults .Furthermore, 
chronic exposure to low amounts of mixtures of EDs than acute exposure to a single 
compound, as in many animal models, is the most possible scenario when studying human 
reproduction. In addition, as in other systems in the organism, EDs effects on human 
reproduction could be varied by individual differences in metabolism, body composition 
and susceptibility due to genetic polymorphisms (Diamanti-Kandarakis et al., 2009). 
In the human female, the first evidence of endocrine disruption was provided almost four 
decades ago by diethylstilbestrol (DES), a synthetic oestrogen prescribed therapeutically in a 
large scale in the mid-20th century in order to prevent miscarriage in pregnant women. The 
observation of an uncommon gynecologic neoplasm, vaginal adenocarcinoma, in daughters 
born 15–22 yr earlier to women treated with this potent synthetic estrogen during 
pregnancy was the first clinical evidence of DES disruption on reproductive system (Herbst 
et al., 1971). Posterior studies have identified additional adverse effects in female off springs 
including increased risk for structural reproductive tract anomalies with a characteristic T-
shaped uterus, infertility, menstrual irregularity and poor pregnancy outcomes manifested 
as spontaneous abortion, ectopic pregnancy, and preterm delivery (Kaufman et al., 1982, 
2000; Palmer et al., 2001). Furthermore, DES grand-daughters born to mothers prenatally 
exposed to diethylstilbestrol exhibit irregular menstrual cycles and possible infertility 
(Titus-Ernstoff et al., 2006) .These robust clinical observations together with experimental 
data support the causal role of DES in female reproductive disorders. 
Increasing data from wildlife and laboratory studies support a role of EDs in the 
pathogenesis of several other female reproductive disorders during a broad developmental 
spectrum from puberty onset to menopause (Diamanti-Kandarakis et al., 2010; McLachlan et 
al., 2006; Woodruff et al., 2008). The catalogue of reproductive aberrations possible related to 
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ED exposure is extending to include early/delayed puberty, polycystic ovarian syndrome 
(PCOS), impaired fertility and fecundity, premature ovarian failure, endometriosis, uterine 
fibroids, aneuploidy, pregnancy complications as well as breast and endometrial tumors 
(Caserta et al., 2008; Diamanti-Kandarakis et al., 2009). 
To give few examples, earlier menarche onset has been observed in girls exposed to 
polychlorinated biphenyls(PCBs), polybrominated biphenyls (PBBs), phthalate esters and 
DDT while there are other data that link phthalates to premature thelarche and increased 
risk of endometriosis (Woodruff et al., 2008). With regard to human puberty, scientific 
interest is focused on the potential effect of environmental factors on puberty timing. This is 
based on the observation that since the 19th century there have been significant 
modifications in puberty timing with earlier age of thelarche and menarche in girls (Euling 
et al., 2008a).This puberty timing alteration has been associated, apart from apparent 
improvements in general health and nutrition, with a potential impact of endocrine-
disrupting chemicals, particularly the estrogen mimics and antiandrogens (Euling et al., 
2008b, Jacobson-Dickman & Lee, 2009). 
Adult female reproductive functions are also disrupted by environmental chemicals with 
the strongest evidence incriminating heavy metals and especially lead exposure. Most 
modifiable risk appears to be associated with exposures in unique populations 
(contaminated fish consumers) or occupational groups (farmworkers) (Mendola et al., 2008). 
Furthermore, recent evidence imply a potential role of Bisphenol A (BPA) in the PCOS 
pathophysiology given that in women with PCOS, BPA levels were found to be higher 
compared to BMI-matched healthy women and also to be positively and strongly associated 
with androgen levels (Kandaraki et al., 2010). Serum BPA concentrations are significantly 
higher in men than in women (Takeuchi et al., 2002) and in women with ovulatory 
dysfunction compared to regularly ovulating women (Takeuchi et al., 2004). As PCOS 
pathogenesis remains partly unraveled, the role of environmental factors and in particular 
BPA could also been proposed in PCOS development. 
With regard to male reproductive system, research has been mainly focused on three major 
health endpoints; impaired semen quality and infertility, urogenital tract abnormalities- 
cryptorchidism and hypospadias- and testicular germ cell cancer. This is probably related to 
the epidemiologic evidence that suggest a decline in human semen quality over the last 50 
years (Carlsen et al., 1992) and temporal increasing trends in the prevalence of urogenital 
tract malformations such as cryptorchidism and hypospadias (Toppari et al., 2001). 
Interestingly, it is hypothesized that the above-mentioned abnormalities share a common 
embryogenic origin as parts of a pathogenic entity coined as “testicular dysgenesis 
syndrome” (TDS). This hypothesis proposes that a prenatal, synergistic, interaction between 
environmental, genetic and maternal factors lead to abnormal testis development 
(dysgenesis)( Skakkebæk et al., 2001) and secondarily to impaired androgen production and 
germ cell development due to Sertoli and Leydig cells’ dysfunction (Sharpe & Skakkebæk, 
2003). The existence of TDS as a distinct clinical entity and of possible associations with EDs 
is an area of active research. 
Some substances that have been incriminated to have an aggravating impact on sperm 
parameters include polychlorinated biphenyls (Dallinga et al., 2002; Hauser et al., 2003), 
phthalates (Duty et al., 2003; Hauser et al., 2006) and non-persistent pesticides (Juhler et al., 
1999; Padungtod et al., 2000).Epidemiologic evidence for EDC exposure and cryptorchidism 
or hypospadias are limited. Concerning ED exposure and cryptorchidism and/or 
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hypospadias, the strongest epidemiological data are those suggesting an association 
between residency in agricultural areas and/or measures of direct parental exposure to non-
organochlorine pesticides (Diamanti-Kandarakis et al., 2009).  
Overall, the epidemiologic data on the environmental EDs suggest that there may be 
associations between exposure and adverse health outcomes in men. However, the limited 
human data highlight the need for further research on these chemicals. Future longitudinal 
epidemiology studies with appropriately designed exposure assessments are needed to 
determine potential causal relationships, to identify the most important time windows of 
exposure, and to define individual susceptibility factors for adverse effects on men's health 
in response to exposure. 
3. Thyroid and endocrine disruptors  
Thyroid hormones have been evolutionarily preserved as important regulators of 
development, tissue growth and metabolism among all vertebrates and in some invertebrate 
species (Heyland and Moroz, 2005). Given their importance for normal physiological 
processes, considerable concern has aroused regarding the clinical impact of environmental 
factors on thyroid function to the extent that human could be affected. This interaction is 
biologically plausible as a variety of heterogeneous synthetic chemicals has been recognized 
to interfere with thyroid homeostasis by acting on different points of regulation of thyroid 
hormone synthesis, release, transport through the blood, metabolism and clearance 
(Howdeshell, 2002) or directly at the receptor level (Zoeller, 2007). 
Polychlorinated biphenyls (PCBs), Polybrominated diphenyl ethers (PBDEs), Bisphenol-A, 
dioxin, Perchlorate and furans have been incriminated as potential disruptors of thyroid 
homeostasis through their ability to affect the hypothalamic- pituitary- thyroid axis (Boas et 
al., 2006; Zoeller, 2010). Correlations between levels of these compounds in the body and 
circulating thyroid hormone levels, thyrotropin levels, thyroid volume and prevalence of 
thyroid antibodies have been reported by several researchers, however, inconsistency exists 
across studies (Hagmar et al., 2001; Langer et al., 2008; Meeker et al., 2007). 
Literature on thyroid disrupting chemicals includes human epidemiological studies that 
indicate a potential association between exposure to endocrine disruptors and disturbance 
of thyroid function (Persky et al., 2001; Steinmaus et al., 2007; Τakser et al., 2005) with most 
data pointing towards subtle alterations of the thyroid axis within normal ranges which 
may, in turn, be harmful especially for human fetus ( Boas et al., 2006). Fetus’ growth and 
brain development are very sensitive to modifications of thyroid homeostasis with a 
significant risk of neurological and cognitive deficiencies.  
Overall, the literature on thyroid-disrupting effects of individual chemicals is rapidly 
increasing, as animal exposure studies and in vitro tests reveal a multitude of potential 
mechanisms of action. Quick and robust tools should be developed to identify potential 
thyroid disrupting chemicals and their multiple mechanisms of action. Furthermore, a better 
understanding of the mechanisms underlying disruption of the thyroid function may lead to 
changes in public policy in order to limit adverse outcomes for future generations. 
4. Obesity epidemic and endocrine disruptors  
A potential role of environmental contaminants on the escalating rates of human obesity has 
been hypothesized as an exogenous factor that may impair body's natural weight-control 
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mechanisms (Baillie-Hamilton, 2002). As the current epidemic in obesity cannot be solely 
explained by alterations in food intake, physical activity and/or genetic predispotion, the 
contribution of environmental factors becomes suspicious. 
Research on this field has been mainly focused on the identification of environmental 
“obesogens”, molecules that inappropriately regulate lipid metabolism and adipogenesis 
and also on the molecular mechanisms underlying these metabolic alterations (Grün et al., 
2006; Tabb & Blumberg, 2006). After all, recent epidemiology studies indicate that exposure 
to EDs during development is associated with overweight and obesity later in life. In a 
cross-sectional analysis of six urinal phthalates metabolites in a total sample of 4369 
participants, positive correlations were observed between body mass index (BMI) and waist 
circumference and most of the metabolites in adult males (Hatch et al., 2008). High serum 
Polychlorinated Bisphenyls levels have been associated with high levels of total serum lipids 
and BMI in a Native American cohort (Goncharov et al., 2008) and prenatal and early life 
PCB exposures were associated with increased weight in boys and girls at puberty (Gladen 
et al., 2000). 
So far, several experimental data have pointed to the effect of endocrine disrupting 
chemicals on lipid metabolism suggesting that adipocyte per se may represent a cell 
vulnerable to disruption. A characteristic example of such interaction is provided by the 
organotin tributyltin (TBT) that has been shown to modulate adipocyte differentiation by 
acting as an agonist for retinoid X receptor (RXR) and peroxisome proliferators-activated 
receptor Ǆ (PPAR Ǆ), the nuclear receptors that play important roles in lipid homeostasis and 
adipogenesis (Grün & Blumberg, 2006; Kanayama et al., 2005). Therefore, as it is speculated 
by Tabb & Blumberg, chronic life-time or developmental exposure to TBT could activate 
RXR and/or RXR:PPAR-Ǆ signalling leading to long-term alterations of the total adipocyte 
number and/or a lipid haemostasis (Tabb & Blumberg, 2006). 
Another chemical showed to display “obesogenic” properties in vivo is diethylstilbestrol. 
Female mice neonatally exposed to both low and high doses of this estrogenic compound 
exhibited increased body weight in adulthood. The low dose did not affect body weight 
during treatment but was associated with a significant increase in body weight in the adult 
animal by 4 to 6 months of age while the highest dose resulted in a significant decrease in 
mice weight during treatment followed by a “catch-up” before puberty and consecutively 
elevated body weight during adulthood (Newbold et al., 2008). Further studies indicated 
that the increase in body weight in DES-exposed mice was associated with an increase in the 
percent of body fat as determined by mouse densitometry (Newbold et al., 2007). 
Bisphenol A is also postulated to play a role in the development of obesity by interacting 
with lipid homeostasis and body weight control mechanisms through pleiotropic modes of 
action. Micromolar concentrations of BPA were shown to enhance adipocyte differentiation 
and lipid accumulation in target cells in a dose-dependent manner (Masuno et al., 2002, 
2005; Wada et al., 2007). From a molecular perspective, these effects are liked with up-
regulation of gene expressions involved in lipid metabolism and adipogenic transcription 
factors (Phrakonkham et al., 2008; Wada et al., 2007). In vivo studies confirm the above 
observations. Perinatal exposure to low doses of BPA increases adipose storage in rodents in 
adult life (Rubin et al, 2001; Somm et al, 2009). A similar effect is observed when exposure 
takes place during gestation (Nikaido et al., 2004). 
Many other environmental chemicals are suspected to be candidate obesogens including 
pesticides; for example, organochlorines such as DDT, endrin, lindane, and 
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hexachlorobenzene; organophosphates; carbamates; polychlorinated biphenyls; other plastic 
components such as phthalates; perfluoroctanoic acid (PFOA); heavy metals such as 
cadmium, lead, and arsenic; and solvents (Newbold, 2010). Although the epidemiological 
link between specific obesogen exposure and obesity is highly suggestive, causality and 
overall significance currently remain ambiguous. New detailed longitudinal studies are 
merited as a high-priority investigative goal to establish the magnitude of the contributing 
risk by individual obesogens. 
5. Metabolic disorders and endocrine disruptors  
The issue of potential ED interference with metabolic imbalances is very timely especially 
in light of a recent cross-sectional study in the general adult population of the United 
States that reported an association between higher urinary BPA concentrations with 
diabetes, cardiovascular diagnoses and clinically abnormal concentrations of the liver 
enzymes Ǆ-glutamyltransferase (Lang et al., 2008). An analysis of the posterior data from 
the US National Health and Nutrition Survey (NHANES) conducted by Melzer et al. 
confirmed the association between urinary BPA levels with coronary heart disease 
(Melzer et al., 2010). 
These adverse effects of BPA on humans’ metabolism appear to be confirmative of 
previously reported actions in animal models. Indeed, a series of studies by Alonso-
Magdalena et al. have illustrated the potency of this estrogenic compound to directly affect 
pancreatic cells’ function and to favor metabolic disorders (Alonso-Magdalena et al., 2005, 
2006, 2010). Low doses of BPA acutely induced a change in glycemic balance characterized 
by a decrease in glycose levels that correlated with a rise of plasma insulin in adult male 
mice (Alonso-Magdalena et al., 2006). Furthermore, long term administration of BPA in ǃ- 
cells from these rodents resulted to an increase in the insulin content and insulin secretion of 
the islets of Langerhans while BPA-treated mice appeared to be insulin resistant (Alonso-
Magdalena et al., 2006). Pancreatic a-cells have also been implied as potential targets for 
endocrine disruption given that low doses of Bisphenol A were shown to impair the 
molecular signaling that leads to secretion of glycagon by suppressing intracellular calcium 
ion oscillations in ǂ-cells in response to low blood glucose levels (Alonso-Magdalena et al., 
2005).  
Interestingly, gestational exposure to BPA has been recently linked to impaired glucose 
tolerance and reduced insulin sensitivity in adult mice’ life when compared with non-
exposed male offspring. Pregnant mothers were also affected as indicated by the aggravated 
insulin resistance during pregnancy and post-partum in this population in comparison to 
non-treated mothers (Alonso-Magdalena et al., 2010). As demonstrated in these rodent 
studies, BPA may contribute to metabolic disorders relevant to glucose homeostasis and, 
therefore, this altered blood glucose homeostasis may subsequently enhance the 
development of type 2 diabetes. Interestingly, human studies have also implied BPA to 
favor metabolic syndrome development through an inhibitory effect on adiponectin release 
from adipose depots of patients with morbidity obesity undergoing gastric bypass surgery 
(Hugo et al., 2008). 
Other compounds that have been correlated with alterations in blood glucose homeostasis 
in humans are dioxins (Bertazzi et al., 2001; Henriksen et al., 1997) and arsenic (Lai et al., 
1994; Meliker et al., 2007).  
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In conclusion, accumulating data are pointing to the potential role of endocrine disrupting 
chemicals either directly or indirectly in the pathogenesis of adipogenesis and diabetes ,the 
major epidemics of modern world. 
6. Conclusion  
Αccumulative evidence from experimental and human studies imply that exposure to 
endocrine disruptors may have significant impact to all hormone-sensitive endocrine 
systems. The catalogue of endocrinopathies possible related to EDs is expanding to 
include a broad spectrum of disorders from reproductive function to metabolic regulation 
(see Table 1). 
Human exposure to EDs is well-documented to occur through multiple sources, however, 
several parameters considerably complicate the assessment of EDs’ interaction with human 
health. For instance, it is important to keep in mind that humans are continuously exposed 
to a multitude of pollutants which can act together, and lead to effects that are different 
from those of the individual pollutants that are usually studied in the laboratory. 
Furthermore, 
the multiplicity of targets and the fact that many targets can be disrupted at the same 
time within an organism make difficult to truly evaluate the affect of an endocrine 
disrupting chemical to many endocrine systems. In addition, humans are not usually 
exposed to a single compound but to a mixture of EDs and as these chemicals may 
interact additively or antagonistically, the final clinical outcome may be variable. After 
all, human disorders are more likely the additive result of chronic exposure to low 
amounts of mixtures of EDs. 
Another important parameter is timing of exposure as the biological effects of a compound 
vary depending not only on the nature of the chemical and dose, but on the susceptibility of 
the individual to this. The timing of exposure appears as a determining factor in the 
developmental programming hypothesis, which proposes that exposure of the developing 
tissues/organs to an adverse stimulus or insult during critical or sensitive times of 
development can permanently reprogram normal physiological responses leading to 
hormonal disorders later in life (Gluckman et al., 2005). In other words, when estimating the 
effect of a compound on human health the time of exposure may determine the clinical 
outcome. Importantly, the consequences of an exposure may not be apparent at the actual 
time of exposure, but may manifest later in life. Indeed, the potential lag between exposure 
to EDs and the manifestation of an endocrine disorder in humans may be years or decades 
after initial exposure. 
Although direct causal links between exposures to EDs and disease states in humans are 
difficult to draw, results from basic research and epidemiological studies make it clear 
that more screening for exposures and targeting at-risk groups is a high priority. 
Innovative technologies designed to improve the assessment of human exposure and 
reproductive and endocrine health endpoints should be applied. Furthermore, scientific 
community should adopt a united approach with collaboration between different 
professional groups and government policy to prompt precautionary actions against 
excess exposure. After all, endocrine disruption is on the agenda of many experts’ groups, 
steering committees and panels of governmental organizations, industry, and academia 
throughout the world. 
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Endocrine systems 
Endocrine Disorders Possibly Related To 
Endocrine Disruptors’ Exposure 
Male reproductive system  
Testicular Dysgenesis Syndrome  
Altered semen quality  
Hypospadias/ cryptorchidism  
Testicular cancer  
Prostate cancer  
Female reproductive system 
Precocious/delayed puberty Impaired 
fertility/fecundity Reproductive tract 
anomalies Endometriosis  
Menstrual and Ovarian dysfunction  
Pregnancy complication (Preterm 
delivery/Pregnancy lost )  
Premature menopause  
Impaired mammary gland differentiation /  
Breast cancer  
Thyroid Altered thyroid hormones  
Adipose tissue 
Promote adipogenesis  
Altered body weight  
Disturbed adipokine secretion  
Pancreas 
Diabetes mellitus  
Disturbed insulin secretion  
Disturbed glycagon secretion  
Table 1. Endocrine system as a target for disruption: The potential impact of endocrine 
disruptors on endocrine system based on experimental and human data. 
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